Holen Sie sich die Stockscreener-App
350.88
1.57%
5.42
Handel nachbörslich:
352.56
1.68
+0.48%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$345.46
Offen:
$346.68
24-Stunden-Volumen:
518.33K
Relative Volume:
0.97
Marktkapitalisierung:
$20.34B
Einnahmen:
$2.91B
Nettoeinkommen (Verlust:
$622.64M
KGV:
33.48
EPS:
10.48
Netto-Cashflow:
$620.14M
1W Leistung:
+2.65%
1M Leistung:
+14.03%
6M Leistung:
-8.75%
1J Leistung:
+8.36%
1-Tages-Spanne:
$344.11
$358.37
1-Wochen-Bereich:
$328.79
$358.37
52-Wochen-Spanne:
$279.24
$423.56
Waters Corp Stock (WAT) Company Profile
Firmenname
Waters Corp
Sektor
Branche
Telefon
(508) 478-2000
Adresse
34 MAPLE ST, MILFORD, MA
Vergleichen Sie WAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
350.88 | 20.34B | 2.91B | 622.64M | 620.14M | 10.48 |
|
TMO
Thermo Fisher Scientific Inc
|
410.78 | 158.51B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
194.82 | 140.78B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
489.98 | 37.91B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
108.70 | 31.23B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.29 | 26.31B | 15.41B | 1.37B | 2.11B | 7.50 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-01 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2023-11-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-05-18 | Eingeleitet | Barclays | Overweight |
| 2022-05-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Hochstufung | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Herabstufung | Needham | Hold → Underperform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Sell |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-01-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Eingeleitet | Needham | Hold |
| 2018-12-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Herabstufung | Goldman | Neutral → Sell |
| 2018-10-11 | Hochstufung | Cleveland Research | Sell → Neutral |
Alle ansehen
Waters Corp Aktie (WAT) Neueste Nachrichten
Analyst Expectations For Waters's Future - Benzinga
Waters (WAT) Stock Price Target Raised by Baird Analyst | WAT Stock News - GuruFocus
UBS Lowers Price Target for Waters (WAT) to $360 | WAT Stock News - GuruFocus
UBS Adjusts Price Target for Waters (WAT) Following Strong Quarter | WAT Stock News - GuruFocus
Waters Corporation (NYSE:WAT) Q1 2025 Earnings Call Transcript - Insider Monkey
Analyst Boosts Price Target for Waters (WAT) Following Strong Q1 Results | WAT Stock News - GuruFocus
Barclays Adjusts Price Target for Waters (WAT) Following Q1 Results | WAT Stock News - GuruFocus
Waters Corp (WAT) Q1 2025 Earnings Call Highlights: Strong Instrument Sales and Raised Guidance ... - Yahoo Finance
Waters Corp (WAT) Q1 2025 Earnings Call Highlights: Strong Instr - GuruFocus
Waters Corporation Reports Strong Q1 2025 Results - TipRanks
Decoding Waters Corp (WAT): A Strategic SWOT Insight - GuruFocus
Waters: Q1 Earnings Snapshot - CTPost
Waters Corp Earnings Call: Strong Growth Amid Challenges - TipRanks
Waters Corporation: Still A Hold After Q1 Earnings (NYSE:WAT) - Seeking Alpha
Waters Earnings: Fair Value Estimate Up Amid Strong Start to 2025, Including Higher Instrument Sales - Morningstar
Waters Is Recovering Following a Post-Pandemic Reset Period - Morningstar
Waters Corp Lifts Profit Forecast After Strong Demand In Asia And Americas - Finimize
Waters Corp (WAT) Q1 2025 Earnings: Revenue Surpasses Estimates at $662M, GAAP EPS Slightly Misses at $2.03 - GuruFocus
Waters Corp. (WAT) Anticipates Strong Sales Growth in Q2 2025 | - GuruFocus
Waters (WAT) Exceeds Q1 Revenue Forecasts with Strong Performanc - GuruFocus
Waters Breakthrough: 6-Month Validation Time Savings for Biopharma Quality Control Testing - Stock Titan
Waters Corp. Q1 Profit Increases, Beats Estimates - Nasdaq
What To Expect From Waters Corporation’s (WAT) Q1 Earnings - Yahoo Finance
Assessing Risky S&P 500 Stocks: EPAM, HPE, and Waters CorpNews and Statistics - IndexBox
Waters Corp (WAT) Stock Price Up 4.63% on Apr 22 - GuruFocus
Is There An Opportunity With Waters Corporation's (NYSE:WAT) 25% Undervaluation? - Yahoo Finance
Waters (WAT) Sees Price Target Reduction by Baird Ahead of Q1 Results | WAT Stock News - GuruFocus
Chromatography Market to Reach $14.37 Billion, Globally, by 2032 at 5.3% CAGR: Coherent Market Insights - GlobeNewswire Inc.
Waters Corp. stock underperforms Tuesday when compared to competitors - MSN
Waters Corp (WAT) Faces Lowered Price Target Amid Industry Conce - GuruFocus
Waters Corp (WAT) Faces Lowered Price Target Amid Industry Concerns | WAT Stock News - GuruFocus
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corporation Q1 Earnings: Global Analytics Leader Sets Key Investor Date - Stock Titan
Option oneJoint waters company with Waikato District Council - Hamilton City Council
Waters expands Alliance iS Bio HPLC product line with Photodiode Array Detector for biopharma development & QC - SelectScience
Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit - ET HealthWorld
Waters (NYSE:WAT) Expands Bio HPLC Line With PDA Detection Enhancing Lab Efficiency - Yahoo Finance
Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC – Company AnnouncementFT.com - Financial Times
KeyBanc raises Waters Corp. stock rating to Overweight By Investing.com - Investing.com Canada
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom By Investing.com - Investing.com South Africa
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom - Investing.com
KeyBanc raises Waters Corp. stock rating to Overweight - Investing.com
Waters Corporation (NYSE:WAT) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - Yahoo Finance
AppLovin shares plunge 20% after third short-selling firm slams company's ad technology - CNBC
AppLovin Shares Sink After Muddy Waters Issues Short Report - Bloomberg.com
Expert Outlook: Waters Through The Eyes Of 7 Analysts - Benzinga
Waters Corporation Stock: Is WAT Outperforming the Healthcare Sector? - Nasdaq
This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
Waters Corporation Stock: Is WAT Outperforming The Healthcare Sector? - Barchart
Baird raises Waters Corp stock rating, price target to $407 - Investing.com
Baird raises Waters Corp stock rating, price target to $407 By Investing.com - Investing.com UK
Finanzdaten der Waters Corp-Aktie (WAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.16%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):